VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 127 filers reported holding VAXCYTE INC in Q3 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,761 | -31.8% | 215,477 | -48.8% | 0.02% | -23.8% |
| Q1 2023 | $15,774 | -37.0% | 420,877 | -19.4% | 0.02% | -38.2% |
| Q4 2022 | $25,029 | -98.9% | 521,977 | +460.1% | 0.03% | +1033.3% |
| Q3 2022 | $2,237,000 | +41.6% | 93,200 | +28.4% | 0.00% | +50.0% |
| Q2 2022 | $1,580,000 | +60.4% | 72,600 | +77.9% | 0.00% | +100.0% |
| Q1 2022 | $985,000 | +218.8% | 40,800 | +213.8% | 0.00% | – |
| Q4 2021 | $309,000 | – | 13,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $99,174,000 | 24.03% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $44,903,000 | 11.24% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,111,485 | $26,442,000 | 11.06% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $54,944,000 | 4.23% |
| Kynam Capital Management, LP | 211,483 | $5,031,000 | 2.69% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,895,000 | 2.64% |
| Ghost Tree Capital, LLC | 250,000 | $5,948,000 | 2.13% |
| RA Capital Management | 4,240,464 | $100,881,000 | 1.78% |
| Opaleye Management Inc. | 315,800 | $7,513,000 | 1.59% |
| Ikarian Capital, LLC | 295,111 | $7,021,000 | 1.05% |